
Daniel Javitt
Director, Division of Experimental Therapetics · New York Presbyterian Hospital
Credentials: · · ·
History
PresentSchizophrenia Research · New York Presbyterian Hospital

- 1988–1989
- 1984–1988

Research
Recent advances in the phencyclidine model of schizophrenia
Review · American Journal of Psychiatry · 1991 · First of 2 authors · 2,465 citations
Review · Trends in Neurosciences · 2008 · 820 citations
Review · Neuropsychopharmacology · 2012 · 792 citations

43 papers · 4 as a fellow

20 papers
- SZ
17 papers
- CC
13 papers

12 papers

10 papers

10 papers

10 papers
Grants
- 2025–2030
National Institute of Mental Health · R01
Contact PI · $1.5M · Nathan s. Kline Institute for Psych Res
- 2024–2029
National Institute of Mental Health · R01
Contact PI · $2.4M · Nathan s. Kline Institute for Psych Res
- 2020–2028
Glutamatergic Mechanisms of Psychosis and Target Engagement
National Institute of Mental Health · R01
PI · $2.9M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
- 2023–2028
National Institute of Mental Health · RF1
Contact PI · $2.3M · Nathan s. Kline Institute for Psych Res
Clinical trials
- 2026–2030
Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Principal investigator · Recruiting
Nathan Kline Institute for Psychiatric Research
- 2025–2028
Temporal Interference Stimulation for Social Cognition
Principal investigator · Recruiting
Columbia University
- 2016–2020
Remediation of Auditory Recognition in Schizophrenia With tDCS
Principal investigator · Completed
New York State Psychiatric Institute
- 2013–2016
Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)
Principal investigator · Withdrawn · Phase 2
New York State Psychiatric Institute

